daunorubicin has been researched along with pirarubicin in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (16.13) | 18.7374 |
1990's | 22 (70.97) | 18.2507 |
2000's | 3 (9.68) | 29.6817 |
2010's | 1 (3.23) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berscheid, HG; Böttger, D; Hermentin, P; Hoffmann, D; Kraemer, HP; Sedlacek, HH | 1 |
Brunet, C; Cazin, JC; Cazin, M; Dine, T; Goudaliez, F; Gressier, B; Luyckx, M; Mallevais, ML; Toraub, I | 1 |
Fukushima, T; Nakamura, T; Ueda, T | 1 |
Araki, Y; Gomita, Y; Shinozawa, S | 1 |
Delius, M; Gambihler, S | 1 |
Izumi, H; Shirai, M; Yamagami, T | 1 |
Frezard, F; Garnier-Suillerot, A | 2 |
Raymond, V; Young, CW | 1 |
Robert, J | 1 |
Gordon, K; Krishan, A; Sauerteig, A; Swinkin, C | 1 |
Umezawa, H | 1 |
Tatsuta, K | 1 |
Iwakawa, S; Nagasawa, K; Nomiyama, M; Ohnishi, N; Okumura, K; Yokoyama, T | 1 |
Borrel, MN; Fiallo, M; Garnier-Suillerot, A; Laigle, A | 1 |
Amirand, C; Ballini, JP; Chinsky, L; Duquesne, M; Fiallo, M; Garnier-Suillerot, A; Jolles, B; Laigle, A; Sureau, F; Turpin, PY | 1 |
Chihara, K; Kitazawa, F; Nagasawa, K; Natazuka, T; Nomiyama, M; Ohnishi, N; Takara, K; Tsumura, A; Yokoyama, T | 1 |
Fiallo, MM; Garnier-Suillerot, A; Laigle, A | 1 |
Nagasawa, K; Nomiyama, M; Ohnishi, N; Takara, K; Yokoyama, T | 1 |
Nagasawa, K; Nomiyama, M; Ohnishi, N; Tsumura, A; Yokoyama, T | 1 |
Horikawa, K; Okada, Y; Sano, M | 1 |
Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S | 1 |
Nagasawa, K; Ohnishi, N; Yokoyama, T | 1 |
Garnier-Suillerot, A; Mankhetkorn, S | 1 |
Bolard, J; Heywang, C; Masson, CM; Saint-Pierre Chazalet, M | 1 |
Garnier-Suillerot, A; Mankhetkorn, S; Teodori, E | 1 |
Fiallo, MM; Garnier-Suillerot, A; Kozlowski, H; Matzanke, B | 1 |
Garnier-Suillerot, A; Marbeuf-Gueye, C; Quidu, P; Salerno, M | 1 |
Drechsel, H; Fiallo, M; Garnier-Suillerot, A; Matzanke, BF; Schünemann, V | 1 |
Miura, T; Muraoka, S | 1 |
Hara, J; Hori, H; Horibe, K; Kato, K; Kobayashi, R; Komada, Y; Kudoh, T; Matsuo, K; Nishimura, S; Oda, M; Tanizawa, A; Tawa, A; Usami, I; Yoshida, M; Yumura-Yagi, K | 1 |
2 review(s) available for daunorubicin and pirarubicin
Article | Year |
---|---|
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Topics: Aclarubicin; Anthraquinones; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Cell Survival; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Leukemia; Menogaril; Mitoxantrone; Naphthacenes; Nogalamycin; Sarcoma; Structure-Activity Relationship | 1986 |
[Pharmacokinetics of new anthracyclines].
Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Epirubicin; Humans; Idarubicin | 1988 |
1 trial(s) available for daunorubicin and pirarubicin
Article | Year |
---|---|
Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Consolidation Chemotherapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Hydrocortisone; Infant; Japan; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Risk; Survival Rate; Treatment Outcome; Vincristine | 2017 |
28 other study(ies) available for daunorubicin and pirarubicin
Article | Year |
---|---|
Structure-activity relationship of anthracyclines in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry, Physical; Colonic Neoplasms; DNA; Humans; Leukemia L1210; Molecular Structure; Neoplasms; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
Topics: Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Drug Stability; Epirubicin; Infusion Pumps; Infusions, Intravenous; Polyvinyl Chloride; Solutions | 1992 |
[Pharmacokinetics and action mechanism of anthracyclines].
Topics: Aclarubicin; Acute Disease; Antibiotics, Antineoplastic; Daunorubicin; DNA; DNA Damage; DNA Replication; Doxorubicin; Humans; Leukemia, Myeloid | 1992 |
[Effects of anthracycline drugs (aclarubicin, daunorubicin, doxorubicin, epirubicin, pirarubicin) on mouse acute toxicity and rat liver microsomal lipid peroxidation].
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Body Weight; Daunorubicin; Doxorubicin; Epirubicin; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Microsomes, Liver; Mitochondria, Liver; Rats; Rats, Inbred Strains | 1992 |
In vitro interaction of lithotripter shock waves and cytotoxic drugs.
Topics: Aclarubicin; Animals; Antineoplastic Agents; Cell Survival; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Leukemia L1210; Lithotripsy; Mice; Tumor Cells, Cultured | 1992 |
Experimental transplantation models of mouse sarcoma 180 in ICR mice for evaluation of anti-tumor drugs.
Topics: Aclarubicin; Animals; Antineoplastic Agents; Daunorubicin; Disease Models, Animal; Doxorubicin; Lung Neoplasms; Male; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Sarcoma 180; Skin Neoplasms; Specific Pathogen-Free Organisms | 1991 |
Comparison of the binding of anthracycline derivatives to purified DNA and to cell nuclei.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Nucleus; Daunorubicin; DNA; Doxorubicin; Kinetics; Molecular Structure; Structure-Activity Relationship | 1990 |
Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
Topics: Animals; Biological Transport; Cell Line; Chlorpromazine; Daunorubicin; Doxorubicin; Flow Cytometry; Fluorometry; Leukemia P388; Leukemia, Experimental; Mice; Monitoring, Physiologic; Trifluoperazine; Tumor Stem Cell Assay; Verapamil | 1986 |
Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Bleomycin; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Lung; Lung Neoplasms; Mice; Molecular Weight; Naphthacenes; Peplomycin; Structure-Activity Relationship | 1982 |
[New anthracycline antibiotics and derivatives].
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Leukemia L1210; Mice; Naphthacenes; Structure-Activity Relationship | 1984 |
Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: uptake of pirarubicin, daunorubicin and doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport, Active; Daunorubicin; Doxorubicin; In Vitro Techniques; Male; Molecular Conformation; Neutrophils; Rats; Rats, Wistar | 1994 |
Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitive and resistant cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buffers; Cell Line; Cell Nucleus; Culture Media; Daunorubicin; DNA; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Membrane Glycoproteins; Spectrometry, Fluorescence; Time Factors | 1993 |
Interactions of iron-anthracycline complexes with living cells: a microspectrofluorometric study.
Topics: Animals; Cell Line; Cell Membrane; Daunorubicin; Diffusion; Doxorubicin; Iron; Organometallic Compounds; Spectrometry, Fluorescence; Structure-Activity Relationship; Tumor Cells, Cultured | 1993 |
Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
Topics: Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport, Active; Blotting, Northern; Cyclosporine; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Genistein; HL-60 Cells; Humans; Isoflavones; Leukemia; RNA, Messenger; RNA, Neoplasm; Temperature; Time Factors; Tumor Cells, Cultured; Verapamil | 1996 |
Spectral shape modifications of anthracyclines bound to cell nuclei: a microspectrofluorometric study.
Topics: Antibiotics, Antineoplastic; Cell Line; Cell Nucleus; Daunorubicin; DNA; Doxorubicin; Humans; Spectrometry, Fluorescence | 1996 |
Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
Topics: 2,4-Dinitrophenol; Antibiotics, Antineoplastic; Antimetabolites; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Humans; Leukemia, Experimental; Tumor Cells, Cultured; Uncoupling Agents | 1996 |
Transport mechanism of pirarubicin in human mononuclear cells.
Topics: Adult; Animals; Antibiotics, Antineoplastic; Antimetabolites; Biological Transport, Active; Daunorubicin; DNA; Doxorubicin; Drug Interactions; Female; Humans; In Vitro Techniques; Kinetics; Leukemia, Experimental; Male; Monocytes; Neutrophils; Rats; Temperature; Tumor Cells, Cultured | 1996 |
[Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy].
Topics: Aclarubicin; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Echocardiography; Epirubicin; Female; Heart; Hematologic Diseases; Humans; Male; Middle Aged; Mitoxantrone; Radionuclide Imaging; Stroke Volume | 1997 |
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine | 1997 |
Transport mechanisms of idarubicin, an anthracycline derivative, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs.
Topics: 2,4-Dinitrophenol; Antibiotics, Antineoplastic; Antimetabolites; Binding Sites; Biological Transport; Biological Transport, Active; Carrier Proteins; Cells, Cultured; Daunorubicin; Diffusion; Dose-Response Relationship, Drug; Doxorubicin; HL-60 Cells; Humans; Idarubicin; Monocytes; Temperature | 1997 |
Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature.
Topics: Antibiotics, Antineoplastic; Cholesterol; Daunorubicin; Diffusion; DNA; Doxorubicin; Drug Compounding; Fluorescence; Kinetics; Lipid Bilayers; Liposomes; Molecular Structure; Permeability; Phospholipids; Protein Conformation; Temperature; Thermodynamics | 1998 |
The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Daunorubicin; Doxorubicin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Idarubicin; Leukemia; Tumor Cells, Cultured; Verapamil | 1998 |
Orientation of anthracyclines in lipid monolayers and planar asymmetrical bilayers: a surface-enhanced resonance Raman scattering study.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Idarubicin; Lipid Bilayers; Molecular Structure; Phosphatidic Acids; Phosphatidylcholines; Phospholipids; Pressure; Scattering, Radiation; Spectrum Analysis, Raman; Surface Properties | 1998 |
Partial inhibition of the P-glycoprotein-mediated transport of anthracyclines in viable resistant K562 cells after irradiation in the presence of a verapamil analogue.
Topics: Anthracyclines; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytosol; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Humans; Idarubicin; K562 Cells; Photoaffinity Labels; Ultraviolet Rays; Verapamil | 1999 |
How Fe3+ binds anthracycline antitumour compounds. The myth and the reality of a chemical sphinx.
Topics: Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Circular Dichroism; Daunorubicin; Doxorubicin; Humans; Hydrogen-Ion Concentration; Idarubicin; Iron; Methanol; Spectrophotometry, Ultraviolet; Sulfonic Acids; Water | 1999 |
Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclic P-Oxides; Daunorubicin; Depression, Chemical; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Fluoresceins; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Nicotinic Acids; Tumor Cells, Cultured | 2000 |
Spectroscopic studies on iron complexes of different anthracyclines in aprotic solvent systems.
Topics: Antibiotics, Antineoplastic; Circular Dichroism; Daunorubicin; Dimethylformamide; Doxorubicin; Electron Spin Resonance Spectroscopy; Ferric Compounds; Fluorometry; Idarubicin; Spectrophotometry, Ultraviolet; Spectroscopy, Mossbauer | 2001 |
Thiol oxidation induced by oxidative action of adriamycin.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Benzoquinones; Creatine Kinase; Daunorubicin; Doxorubicin; Electron Spin Resonance Spectroscopy; Epirubicin; Free Radicals; Glutathione; Horseradish Peroxidase; Hydrogen Peroxide; Hypoxanthine; Idarubicin; Oxidation-Reduction; Sulfhydryl Compounds; Xanthine Oxidase | 2004 |